The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cattle and Sheep Routine Vaccine Market Research Report 2024
Synopsis
Routine vaccination programs for cattle and sheep are essential for maintaining herd health, preventing disease outbreaks, and optimizing production in livestock operations. The specific vaccines administered to cattle and sheep may vary based on factors such as geographic location, herd size, management practices, and disease prevalence.
The global Cattle and Sheep Routine Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cattle and Sheep Routine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cattle and Sheep Routine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cattle and Sheep Routine Vaccine include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cattle and Sheep Routine Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle and Sheep Routine Vaccine.
The Cattle and Sheep Routine Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cattle and Sheep Routine Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cattle and Sheep Routine Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U.
Indian Immunologicals Ltd.
Vaxxinova International BV (EW Group)
Jinyu Bio-Technology
CNBG
China Animal Husbandry Industry Co., Ltd.
Segment by Type
Modified/ Attenuated Live Vaccines
Inactivated (Killed) Vaccines
Others
Segment by Application
Cattle
Sheep & Goats
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cattle and Sheep Routine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cattle and Sheep Routine Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Routine vaccination programs for cattle and sheep are essential for maintaining herd health, preventing disease outbreaks, and optimizing production in livestock operations. The specific vaccines administered to cattle and sheep may vary based on factors such as geographic location, herd size, management practices, and disease prevalence.
The global Cattle and Sheep Routine Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cattle and Sheep Routine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cattle and Sheep Routine Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cattle and Sheep Routine Vaccine include Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., Virbac, Ceva Sante Animale, CZ Vaccines S.A.U., Indian Immunologicals Ltd., Vaxxinova International BV (EW Group), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cattle and Sheep Routine Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cattle and Sheep Routine Vaccine.
The Cattle and Sheep Routine Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cattle and Sheep Routine Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cattle and Sheep Routine Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U.
Indian Immunologicals Ltd.
Vaxxinova International BV (EW Group)
Jinyu Bio-Technology
CNBG
China Animal Husbandry Industry Co., Ltd.
Segment by Type
Modified/ Attenuated Live Vaccines
Inactivated (Killed) Vaccines
Others
Segment by Application
Cattle
Sheep & Goats
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cattle and Sheep Routine Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cattle and Sheep Routine Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cattle and Sheep Routine Vaccine Market Overview
1.1 Product Definition
1.2 Cattle and Sheep Routine Vaccine by Type
1.2.1 Global Cattle and Sheep Routine Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Modified/ Attenuated Live Vaccines
1.2.3 Inactivated (Killed) Vaccines
1.2.4 Others
1.3 Cattle and Sheep Routine Vaccine by Application
1.3.1 Global Cattle and Sheep Routine Vaccine Market Value by Application (2024-2030)
1.3.2 Cattle
1.3.3 Sheep & Goats
1.4 Global Cattle and Sheep Routine Vaccine Market Size Estimates and Forecasts
1.4.1 Global Cattle and Sheep Routine Vaccine Revenue 2019-2030
1.4.2 Global Cattle and Sheep Routine Vaccine Sales 2019-2030
1.4.3 Global Cattle and Sheep Routine Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cattle and Sheep Routine Vaccine Market Competition by Manufacturers
2.1 Global Cattle and Sheep Routine Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cattle and Sheep Routine Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cattle and Sheep Routine Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Date of Enter into This Industry
2.8 Global Cattle and Sheep Routine Vaccine Market Competitive Situation and Trends
2.8.1 Global Cattle and Sheep Routine Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cattle and Sheep Routine Vaccine Players Market Share by Revenue
2.8.3 Global Cattle and Sheep Routine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cattle and Sheep Routine Vaccine Market Scenario by Region
3.1 Global Cattle and Sheep Routine Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cattle and Sheep Routine Vaccine Sales by Region: 2019-2030
3.2.1 Global Cattle and Sheep Routine Vaccine Sales by Region: 2019-2024
3.2.2 Global Cattle and Sheep Routine Vaccine Sales by Region: 2025-2030
3.3 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2019-2030
3.3.1 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2019-2024
3.3.2 Global Cattle and Sheep Routine Vaccine Revenue by Region: 2025-2030
3.4 North America Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.4.1 North America Cattle and Sheep Routine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cattle and Sheep Routine Vaccine Sales by Country (2019-2030)
3.4.3 North America Cattle and Sheep Routine Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.5.1 Europe Cattle and Sheep Routine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cattle and Sheep Routine Vaccine Sales by Country (2019-2030)
3.5.3 Europe Cattle and Sheep Routine Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cattle and Sheep Routine Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Cattle and Sheep Routine Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.7.1 Latin America Cattle and Sheep Routine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cattle and Sheep Routine Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Cattle and Sheep Routine Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cattle and Sheep Routine Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cattle and Sheep Routine Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cattle and Sheep Routine Vaccine Sales by Type (2019-2030)
4.1.1 Global Cattle and Sheep Routine Vaccine Sales by Type (2019-2024)
4.1.2 Global Cattle and Sheep Routine Vaccine Sales by Type (2025-2030)
4.1.3 Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Cattle and Sheep Routine Vaccine Revenue by Type (2019-2030)
4.2.1 Global Cattle and Sheep Routine Vaccine Revenue by Type (2019-2024)
4.2.2 Global Cattle and Sheep Routine Vaccine Revenue by Type (2025-2030)
4.2.3 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Cattle and Sheep Routine Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cattle and Sheep Routine Vaccine Sales by Application (2019-2030)
5.1.1 Global Cattle and Sheep Routine Vaccine Sales by Application (2019-2024)
5.1.2 Global Cattle and Sheep Routine Vaccine Sales by Application (2025-2030)
5.1.3 Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Cattle and Sheep Routine Vaccine Revenue by Application (2019-2030)
5.2.1 Global Cattle and Sheep Routine Vaccine Revenue by Application (2019-2024)
5.2.2 Global Cattle and Sheep Routine Vaccine Revenue by Application (2025-2030)
5.2.3 Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Cattle and Sheep Routine Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim International GmbH
6.1.1 Boehringer Ingelheim International GmbH Company Information
6.1.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.2 Zoetis, Inc.
6.2.1 Zoetis, Inc. Company Information
6.2.2 Zoetis, Inc. Description and Business Overview
6.2.3 Zoetis, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.2.5 Zoetis, Inc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Company Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Bimeda, Inc.
6.4.1 Bimeda, Inc. Company Information
6.4.2 Bimeda, Inc. Description and Business Overview
6.4.3 Bimeda, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bimeda, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.4.5 Bimeda, Inc. Recent Developments/Updates
6.5 Elanco Animal Health, Inc.
6.5.1 Elanco Animal Health, Inc. Company Information
6.5.2 Elanco Animal Health, Inc. Description and Business Overview
6.5.3 Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Product Portfolio
6.5.5 Elanco Animal Health, Inc. Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Cattle and Sheep Routine Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.7.1 Ceva Sante Animale Company Information
6.7.2 Ceva Sante Animale Description and Business Overview
6.7.3 Ceva Sante Animale Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ceva Sante Animale Cattle and Sheep Routine Vaccine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 CZ Vaccines S.A.U.
6.8.1 CZ Vaccines S.A.U. Company Information
6.8.2 CZ Vaccines S.A.U. Description and Business Overview
6.8.3 CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Product Portfolio
6.8.5 CZ Vaccines S.A.U. Recent Developments/Updates
6.9 Indian Immunologicals Ltd.
6.9.1 Indian Immunologicals Ltd. Company Information
6.9.2 Indian Immunologicals Ltd. Description and Business Overview
6.9.3 Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Product Portfolio
6.9.5 Indian Immunologicals Ltd. Recent Developments/Updates
6.10 Vaxxinova International BV (EW Group)
6.10.1 Vaxxinova International BV (EW Group) Company Information
6.10.2 Vaxxinova International BV (EW Group) Description and Business Overview
6.10.3 Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Product Portfolio
6.10.5 Vaxxinova International BV (EW Group) Recent Developments/Updates
6.11 Jinyu Bio-Technology
6.11.1 Jinyu Bio-Technology Company Information
6.11.2 Jinyu Bio-Technology Description and Business Overview
6.11.3 Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Product Portfolio
6.11.5 Jinyu Bio-Technology Recent Developments/Updates
6.12 CNBG
6.12.1 CNBG Company Information
6.12.2 CNBG Description and Business Overview
6.12.3 CNBG Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CNBG Cattle and Sheep Routine Vaccine Product Portfolio
6.12.5 CNBG Recent Developments/Updates
6.13 China Animal Husbandry Industry Co., Ltd.
6.13.1 China Animal Husbandry Industry Co., Ltd. Company Information
6.13.2 China Animal Husbandry Industry Co., Ltd. Description and Business Overview
6.13.3 China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Product Portfolio
6.13.5 China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cattle and Sheep Routine Vaccine Industry Chain Analysis
7.2 Cattle and Sheep Routine Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cattle and Sheep Routine Vaccine Production Mode & Process
7.4 Cattle and Sheep Routine Vaccine Sales and Marketing
7.4.1 Cattle and Sheep Routine Vaccine Sales Channels
7.4.2 Cattle and Sheep Routine Vaccine Distributors
7.5 Cattle and Sheep Routine Vaccine Customers
8 Cattle and Sheep Routine Vaccine Market Dynamics
8.1 Cattle and Sheep Routine Vaccine Industry Trends
8.2 Cattle and Sheep Routine Vaccine Market Drivers
8.3 Cattle and Sheep Routine Vaccine Market Challenges
8.4 Cattle and Sheep Routine Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cattle and Sheep Routine Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cattle and Sheep Routine Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Cattle and Sheep Routine Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cattle and Sheep Routine Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Cattle and Sheep Routine Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cattle and Sheep Routine Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cattle and Sheep Routine Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cattle and Sheep Routine Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Cattle and Sheep Routine Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cattle and Sheep Routine Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cattle and Sheep Routine Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cattle and Sheep Routine Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cattle and Sheep Routine Vaccine Sales by Region (2019-2024) & (K Dose)
Table 18. Global Cattle and Sheep Routine Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Cattle and Sheep Routine Vaccine Sales by Region (2025-2030) & (K Dose)
Table 20. Global Cattle and Sheep Routine Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Cattle and Sheep Routine Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Cattle and Sheep Routine Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Cattle and Sheep Routine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cattle and Sheep Routine Vaccine Sales by Country (2019-2024) & (K Dose)
Table 27. North America Cattle and Sheep Routine Vaccine Sales by Country (2025-2030) & (K Dose)
Table 28. North America Cattle and Sheep Routine Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cattle and Sheep Routine Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cattle and Sheep Routine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cattle and Sheep Routine Vaccine Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Cattle and Sheep Routine Vaccine Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Cattle and Sheep Routine Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cattle and Sheep Routine Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Cattle and Sheep Routine Vaccine Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cattle and Sheep Routine Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cattle and Sheep Routine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cattle and Sheep Routine Vaccine Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Cattle and Sheep Routine Vaccine Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Cattle and Sheep Routine Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Cattle and Sheep Routine Vaccine Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Type (2019-2024)
Table 51. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Type (2025-2030)
Table 52. Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Cattle and Sheep Routine Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Application (2019-2024)
Table 61. Global Cattle and Sheep Routine Vaccine Sales (K Dose) by Application (2025-2030)
Table 62. Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Cattle and Sheep Routine Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cattle and Sheep Routine Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Cattle and Sheep Routine Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Boehringer Ingelheim International GmbH Company Information
Table 71. Boehringer Ingelheim International GmbH Description and Business Overview
Table 72. Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim International GmbH Cattle and Sheep Routine Vaccine Product
Table 74. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 75. Zoetis, Inc. Company Information
Table 76. Zoetis, Inc. Description and Business Overview
Table 77. Zoetis, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Zoetis, Inc. Cattle and Sheep Routine Vaccine Product
Table 79. Zoetis, Inc. Recent Developments/Updates
Table 80. Merck & Co., Inc. Company Information
Table 81. Merck & Co., Inc. Description and Business Overview
Table 82. Merck & Co., Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Merck & Co., Inc. Cattle and Sheep Routine Vaccine Product
Table 84. Merck & Co., Inc. Recent Developments/Updates
Table 85. Bimeda, Inc. Company Information
Table 86. Bimeda, Inc. Description and Business Overview
Table 87. Bimeda, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Bimeda, Inc. Cattle and Sheep Routine Vaccine Product
Table 89. Bimeda, Inc. Recent Developments/Updates
Table 90. Elanco Animal Health, Inc. Company Information
Table 91. Elanco Animal Health, Inc. Description and Business Overview
Table 92. Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Elanco Animal Health, Inc. Cattle and Sheep Routine Vaccine Product
Table 94. Elanco Animal Health, Inc. Recent Developments/Updates
Table 95. Virbac Company Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Virbac Cattle and Sheep Routine Vaccine Product
Table 99. Virbac Recent Developments/Updates
Table 100. Ceva Sante Animale Company Information
Table 101. Ceva Sante Animale Description and Business Overview
Table 102. Ceva Sante Animale Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Ceva Sante Animale Cattle and Sheep Routine Vaccine Product
Table 104. Ceva Sante Animale Recent Developments/Updates
Table 105. CZ Vaccines S.A.U. Company Information
Table 106. CZ Vaccines S.A.U. Description and Business Overview
Table 107. CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. CZ Vaccines S.A.U. Cattle and Sheep Routine Vaccine Product
Table 109. CZ Vaccines S.A.U. Recent Developments/Updates
Table 110. Indian Immunologicals Ltd. Company Information
Table 111. Indian Immunologicals Ltd. Description and Business Overview
Table 112. Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Indian Immunologicals Ltd. Cattle and Sheep Routine Vaccine Product
Table 114. Indian Immunologicals Ltd. Recent Developments/Updates
Table 115. Vaxxinova International BV (EW Group) Company Information
Table 116. Vaxxinova International BV (EW Group) Description and Business Overview
Table 117. Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Vaxxinova International BV (EW Group) Cattle and Sheep Routine Vaccine Product
Table 119. Vaxxinova International BV (EW Group) Recent Developments/Updates
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Description and Business Overview
Table 122. Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Jinyu Bio-Technology Cattle and Sheep Routine Vaccine Product
Table 124. Jinyu Bio-Technology Recent Developments/Updates
Table 125. CNBG Company Information
Table 126. CNBG Description and Business Overview
Table 127. CNBG Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. CNBG Cattle and Sheep Routine Vaccine Product
Table 129. CNBG Recent Developments/Updates
Table 130. China Animal Husbandry Industry Co., Ltd. Company Information
Table 131. China Animal Husbandry Industry Co., Ltd. Description and Business Overview
Table 132. China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. China Animal Husbandry Industry Co., Ltd. Cattle and Sheep Routine Vaccine Product
Table 134. China Animal Husbandry Industry Co., Ltd. Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Cattle and Sheep Routine Vaccine Distributors List
Table 138. Cattle and Sheep Routine Vaccine Customers List
Table 139. Cattle and Sheep Routine Vaccine Market Trends
Table 140. Cattle and Sheep Routine Vaccine Market Drivers
Table 141. Cattle and Sheep Routine Vaccine Market Challenges
Table 142. Cattle and Sheep Routine Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cattle and Sheep Routine Vaccine
Figure 2. Global Cattle and Sheep Routine Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cattle and Sheep Routine Vaccine Market Share by Type: 2023 & 2030
Figure 4. Modified/ Attenuated Live Vaccines Product Picture
Figure 5. Inactivated (Killed) Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cattle and Sheep Routine Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Cattle and Sheep Routine Vaccine Market Share by Application: 2023 & 2030
Figure 9. Cattle
Figure 10. Sheep & Goats
Figure 11. Global Cattle and Sheep Routine Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cattle and Sheep Routine Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Cattle and Sheep Routine Vaccine Sales (2019-2030) & (K Dose)
Figure 14. Global Cattle and Sheep Routine Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 15. Cattle and Sheep Routine Vaccine Report Years Considered
Figure 16. Cattle and Sheep Routine Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Cattle and Sheep Routine Vaccine Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Cattle and Sheep Routine Vaccine Players: Market Share by Revenue in Cattle and Sheep Routine Vaccine in 2023
Figure 19. Cattle and Sheep Routine Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Cattle and Sheep Routine Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Cattle and Sheep Routine Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Cattle and Sheep Routine Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Cattle and Sheep Routine Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Cattle and Sheep Routine Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Cattle and Sheep Routine Vaccine Sales Market Share by Country (2019-2030)
Figure 42. Mexico Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Cattle and Sheep Routine Vaccine Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Cattle and Sheep Routine Vaccine Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Cattle and Sheep Routine Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Cattle and Sheep Routine Vaccine by Type (2019-2030)
Figure 52. Global Revenue Market Share of Cattle and Sheep Routine Vaccine by Type (2019-2030)
Figure 53. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of Cattle and Sheep Routine Vaccine by Application (2019-2030)
Figure 55. Global Revenue Market Share of Cattle and Sheep Routine Vaccine by Application (2019-2030)
Figure 56. Global Cattle and Sheep Routine Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 57. Cattle and Sheep Routine Vaccine Value Chain
Figure 58. Cattle and Sheep Routine Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
